Natco Pharma to raise Rs 1,279 cr via rights issue at Rs 750/share

Corporate Actions View source PDF Explain this filing

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹842.20

prior close

₹845.15

announcement price

In-mkt

timing

Nifty Smallcap 250market+0.0%-0.6% vs market

Pharmaceuticals peers, median of 171sector-0.0%-0.6% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Smallcap 250 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.1

15m

-0.1

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6+0.0-0.6-0.0-0.6

Next day

-1.7-1.6-0.1-1.3-0.4

+0.0-2.2+2.3-0.6+0.6

-1.9-2.0+0.0-1.6-0.3

-2.8-3.1+0.4-2.5-0.3

-2.4-2.8+0.4-2.7+0.3

-3.7-1.3-2.4-2.2-1.5

15d

-4.7-4.0-0.7-6.1+1.4

-5.8-8.7+2.9-9.3+3.5

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 171Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Natco Pharma board approved a rights issue of about 1.71 crore equity shares at Rs 750 each, aggregating up to Rs 1,279.35 crores. Ratio is 2 rights shares for every 21 held. Record date is October 1, 2026. Issue opens October 12 and closes October 22, 2026. Post-issue share count rises to 19.62 crore from 17.91 crore, assuming full subscription.

Likely market impact

Eligible shareholders can subscribe proportionally or renounce rights; non-subscription may dilute holdings; company raises growth capital.